Dec 28, 2020 (The Expresswire) -- Global “ Colorectal Cancer Screening Market ”Report 2021 studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors, and Porter's Five Forces Analysis. Also, Colorectal Cancer Screening Market is predicted to grow at a CAGR of Growing rate during the forecast period. And report provides a complete market overview, a list of top manufactures, the scope of the report, key market trends of the Colorectal Cancer Screening market, and the main aspect of the report- why do you have to buy this research report? So don’t miss it.
The report gives - Who are the global key players in this keyword market? What are their company profile, product information, and contact information? What Was the Global Market Status of Colorectal Cancer Screening Market? What Was Capacity, Production Value, Cost and PROFIT of Colorectal Cancer Screening Market?
Get a Sample PDF of Colorectal Cancer Screening Market 2021
Colorectal Cancer Screening Market Overview 2021:
The global market for colorectal cancer screening has been estimated at USD 727.08 million for 2017. The market is expected to register a CAGR of 4.38% during the forecast period, 2018 to 2023. Asia-Pacific is expected to have a substantial growth in the forecast period.
The Advent of Efficacious Genetic Tests
Genetic testing for colon cancer creates better opportunity for early diagnosis. It is highly recommended by the medical community. Screening for the mutations that cause colon cancer is only beginning to be done outside the research labs. If these medical screenings are implemented, then the number of colon cancer cases found in the early stages would increase. Also, gene therapies to alter these mutations is likely to be developed. The increasing awareness about genetic screening methods and advantages in undergoing the testânot for early detection and treatment but also for removal of precancerous cells, which is much cheaper than the usual run of chemotherapyâis driving the market.
Additionally, increase in prevalence population, potential product pipeline and increasing cancer prevention initiatives are also fuelling global colorectal cancer screening market.
High Screening Tests Cost
Many high-income countries, including the United Kingdom and the United States, are facing the challenge of providing care to an ever-increasing population of patients with cancer, owing to expensive screening and treatment. Though the CRC screening tests have potential for early disease detection, they are seldom used. The high cost of these tests is hindering the market growth. The spending associated with a CRC diagnosis increases quickly, even if one has insurance. Although many private insurance plans cover the costs for colonoscopy as a screening test, patients still might be charged for some services, which is again a burden. Not all screening test costs are covered by insurance companies; e.g.: Medicare does not cover the cost of virtual colonoscopy (CT colonography, which is more expensive than colonoscopy).
In addition, inadequate healthcare access in developing countries and lack of screening guidelines in Asia-Pacific is restraining the Global Colorectal Cancer Screening Market.
North America to Dominate the Market
The Global Colorectal Cancer Screening Tests Market is segmented into by test type which is further segmented into Guaiac fecal occult blood test, fecal immunochemical, stool DNA and others. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America is dominating the Colorectal Cancer Screening Tests Market due to high incidences of colorectal cancer and rise of the geriatric population in the North American region. Colon cancer is reported to be Americaâs second deadliest cancer with 50,000 deaths, annually, followed by lung cancer. Rising incidence of colorectal cancer is driving the market in the United States; approximately 1, 44,000 cases of colorectal cancer were found in 2015 in the country and 1, 60, 000 new cases for colorectal cancer are expected to occur by 2020. This increase in the disease occurrence will eventually increase the demand for colorectal cancer screening procedures.
Get a Sample PDF of the Report @ https://www.360marketupdates.com/enquiry/request-sample/12884249
Top Key-players/Leading Manufacturers of Colorectal Cancer Screening Market:
● ALERE INC ● CLINICAL GENOMICS ● BECKMAN COULTER ● ABBOTT LABORATORIES ● EXACT SCIENCES CORP ● HEMOSURE ● EIKEN CHEMICAL ● QUIDEL CORPORATION ● NOVIGENIX SA ● SYSMEX CORPORATION ● EPIGENOMICS AG
With tables and figures helping analyze the worldwide Global Colorectal Cancer Screening market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
The Global Colorectal Cancer Screening market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.
TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT - REQUEST SAMPLE
Key Developments in the Colorectal Cancer Screening Market:
This Colorectal Cancer Screening Market Research/analysis Report Contains Answers to your following Questions
Inquire more and share questions if any before the purchase of this report @ https://www.360marketupdates.com/enquiry/pre-order-enquiry/12884249
Reasons to Purchase Colorectal Cancer Screening Market Report:
Purchase this report (Price 4250 USD for a single-user license) @ https://www.360marketupdates.com/purchase/12884249
About 360 Market Updates: